ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $150,822,429 | +7.3% | 3,816,357 | +9.1% | 0.04% | -2.7% |
| Q3 2022 | $140,533,729 | -1.5% | 3,497,604 | +3.1% | 0.04% | 0.0% |
| Q2 2022 | $142,662,614 | +19.2% | 3,393,497 | +10.5% | 0.04% | +42.3% |
| Q1 2022 | $119,661,588 | +1.4% | 3,071,396 | +3.8% | 0.03% | +8.3% |
| Q4 2021 | $117,966,000 | +14.1% | 2,960,240 | +3.5% | 0.02% | +4.3% |
| Q3 2021 | $103,387,000 | -9.8% | 2,860,730 | +2.4% | 0.02% | -8.0% |
| Q2 2021 | $114,565,000 | -4.9% | 2,794,952 | +1.2% | 0.02% | -10.7% |
| Q1 2021 | $120,528,000 | +135.5% | 2,763,137 | +170.2% | 0.03% | +133.3% |
| Q4 2020 | $51,180,000 | +68.4% | 1,022,571 | +41.6% | 0.01% | +50.0% |
| Q3 2020 | $30,390,000 | -72.8% | 722,363 | -68.6% | 0.01% | -75.0% |
| Q2 2020 | $111,787,000 | – | 2,302,508 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |